Here are six takeaways:
1. At six months, Intralink-Spine announced it has demonstrated the safety of the device.
2. Among patients implanted with the device, lumbar range of motion increased by an average of nine degrees.
3. The study also revealed a statistically significant 25 percent increase in treated level lordosis.
4. At six months, 80 percent of patients saw pain and disability decrease by more than 50 percent.
5. Further, patient data shows treatment effects at two weeks post-implant.
6. Tom Hedman, PhD, adjunct associate professor in the Lexington-based University of Kentucky’s F. Joseph Halcomb III, M.D. Department of Biomedical Engineering, invented the Réjuve System.
More articles on devices:
DePuy Synthes receives up to $260M US Department of Defense contract: 5 key notes
Mazor, Xtant Medical, InVivo Therapeutics & more: 18 device company key notes
Histogenics receives innovation award
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
